Academic Medical Center
Appears in 2 stories
Institution hosting the research team
Some prostate cancer tumors survive treatment by changing what they are—losing glandular identity and adopting stem-cell-like traits, a process called transdifferentiation. A University of Michigan team showed in JCI Insight that combining two drug classes reverses many of those changes and sharply slows tumor growth in mice.
Updated 4 days ago
Institution behind the research
Severe fatty liver disease has almost no drugs that reverse it. On July 11, 2026, a University of Michigan team reported that an experimental compound called DT-109 did exactly that in mice and monkeys, by fixing the gut instead of the liver.
Updated Jul 11
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
